Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
HLscience Co. (239610 KS)
Watchlist
16
Analysis
Consumer Discretionary
•
South Korea
HLSCIENCE Co., Ltd. researches and develops bio healthcare products. The Company offers natural and functional materials, as well as manufactures and distributes health supplements.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Thematic (Sector/Industry)
•
24 Feb 2017 11:39
Korean Govt Measures To Invigorate Domestic Consumption
On February 23rd, the Korean government announced numerous domestic consumption boosting measures. Among them included a discount of 30-50% on KTX...
Douglas Kim
Follow
2.7k Views
Share
bearish
•
Thematic (Sector/Industry)
•
09 Jan 2017 05:41
Stark Reality of VR Market - Telcos Are Pushing VR for 5G in Korea
Virtual Reality (VR) is not really taking off. We had and we are still having high expectations on VR, but the actual sales numbers are quite...
Sanghyun Park
Follow
1.5k Views
Share
bullish
•
Thematic (Sector/Industry)
•
27 Aug 2016 17:46
Who Is AJ Networks (095570)? Most Favored Bidder for Tongyang Magic
Glenwood Private Equity and NH Private Equity selected a shortlist of seven bidders who had made it to the second round of bidding for Tongyang...
Sanghyun Park
Follow
503 Views
Share
bullish
•
Thematic (Sector/Industry)
•
22 Jul 2016 14:24
Korean Government Announces 109 Trillion Won in Spending Measures to Boost Birth Rates
South Korea is following in the footsteps of Japan in declining birth rates. Unless radical steps are taken (or if there is unforeseen macro event...
Douglas Kim
Follow
391 Views
Share
bullish
•
Thematic (Sector/Industry)
•
14 Apr 2016 16:49
Coupang: Taking Amazon's Market Share at All Cost Strategy (Coupang's 2015 Financials Are Out)
Coupang's 2015 financials came out today. This is perhaps the most awaited financials among private companies in Korea. As one of the largest...
Douglas Kim
Follow
605 Views
Share
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.69.1
x